Testicular and ovarian Juvenile granulosa cell tumors in children and adolescents: Analysis of 113 patients registered to the German Registry for Rare Pediatric Tumors (STEP)
Testicular and ovarian juvGCTs are clinically distinct entities. Although testicular juvGCTs exclusively present during infancy and have an excellent prognosis, ovarian juvGCTs may arise at any age and constitute potentially aggressive tumors. Centralized reference diagnostics and the establishment of counseling structures for the treatment of patients with ovarian juvGCTs improved prognosis compared with historical groups. The mitotic rate and incomplete surgery were identified as important risk factors in addition to tumor stage and should be considered in the risk-stratification of therapy.
Authors
- Tabea Blessing
- Martin Benesch (ORCID: https://orcid.org/0000-0001-7827-4130)
- Gabriele Calaminus (ORCID: https://orcid.org/0000-0002-7893-7982)
- Norbert M. Graf (ORCID: https://orcid.org/0000-0002-2248-323X)
- Ines B. Brecht (ORCID: https://orcid.org/0000-0001-7973-3300)
- Kris Ann P. Schultz (ORCID: https://orcid.org/0000-0002-1788-5832)
- Andrea Witowski
- Benedikt Bernbeck (ORCID: https://orcid.org/0000-0001-7700-7743)
- Michael Abele (ORCID: https://orcid.org/0000-0002-9780-603X)
- Christian Vokuhl (ORCID: https://orcid.org/0000-0002-4138-4536)
- Dominik T. Schneider (ORCID: https://orcid.org/0000-0001-8153-1601)
- U. Göbel
- Bastian Brummel
Institutions
- University of Bonn (DE)
- Medical University of Graz (AT)
- University Hospital Bonn (DE)
- Center for Cancer and Blood Disorders (US)
- University Children's Hospital Tübingen (DE)
- Klinikum Dortmund (DE)
- Children's Minnesota (US)
- Heinrich Heine University Düsseldorf (DE)
- Saarland University (DE)
Publication Details
- Journal
- Cancer
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1002/cncr.35861
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Kinderkrebsstiftung
- National Institutes of Health
- National Cancer Institute